Evaluation of Satisfaction in Patients Receiving PegIntron Pen [peginterferon alfa-2b]/Rebetol [ribavirin] for Hepatitis C
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2014
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms SATISFACTION
- Sponsors Schering-Plough
- 07 Aug 2009 Actual patient number changed from (1960) to (1955) as reported by ClinicalTrials.gov.
- 20 Aug 2008 New trial record.